Windsor Framework replaces the Northern Ireland protocol to address issues and provide significant c...
Read moreTLV unveils annual report, offering insights into trends and projects that have dominated the past y...
Read moreCMS denies coverage of FDA-approved treatments that target amyloid for Alzheimer's disease unless th...
Read moreABPI announces new VPAG, which focuses on restoring the commercially competitive environment for lif...
Read moreNew process to assess clinical and cost-effectiveness of COVID-19 treatments to get these medicines ...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreTwo global pharma companies withdraw from the UK’s Voluntary Scheme for Branded Medicines Pricing ...
Read moreOur experts provide an overview of the five key trends that could shape the pricing and market acces...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read more